Table 1 Selected PPAR-targeted drugs in Phase II or III trials * Full size table Many research groups have “been fishing with the wrong bait” in trying to develop effective and safe anti ...
Fibrates are widely prescribed agonists of transcription factor peroxisome proliferator-activated receptor (PPAR)-α, and are used to treat patients with atherogenic dyslipidemia. These drugs ...